These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 21760546)

  • 1. Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children.
    Grønbæk H; Lange A; Birkebæk NH; Holland-Fischer P; Solvig J; Hørlyck A; Kristensen K; Rittig S; Vilstrup H
    J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):223-8. PubMed ID: 21760546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss.
    Reinehr T; Roth CL
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4479-85. PubMed ID: 18728159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis.
    Reinehr T; Woelfle J; Wunsch R; Roth CL
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2143-50. PubMed ID: 22438225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children.
    Bedogni G; Gastaldelli A; Manco M; De Col A; Agosti F; Tiribelli C; Sartorio A
    Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):120-6. PubMed ID: 20880682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents.
    de Piano A; de Mello MT; Sanches Pde L; da Silva PL; Campos RM; Carnier J; Corgosinho F; Foschini D; Masquio DL; Tock L; Oyama LM; do Nascimento CM; Tufik S; Dâmaso AR
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1313-24. PubMed ID: 22932160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver steatosis in obese prepubertal children: a possible role of insulin resistance.
    D'Adamo E; Impicciatore M; Capanna R; Loredana Marcovecchio M; Masuccio FG; Chiarelli F; Mohn AA
    Obesity (Silver Spring); 2008 Mar; 16(3):677-83. PubMed ID: 18239582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced sCD36 following weight loss corresponds to improved insulin sensitivity, dyslipidemia and liver fat in obese children.
    Knøsgaard L; Kazankov K; Birkebæk NH; Holland-Fischer P; Lange A; Solvig J; Hørlyck A; Kristensen K; Rittig S; Vilstrup H; Grønbæk H; Handberg A
    Eur J Clin Nutr; 2016 Sep; 70(9):1073-7. PubMed ID: 27273071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial.
    Nobili V; Manco M; Devito R; Di Ciommo V; Comparcola D; Sartorelli MR; Piemonte F; Marcellini M; Angulo P
    Hepatology; 2008 Jul; 48(1):119-28. PubMed ID: 18537181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents.
    Ciba I; Widhalm K
    Acta Paediatr; 2007 Jan; 96(1):109-12. PubMed ID: 17187615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic steatosis in obese Chinese children.
    Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
    Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of non-alcoholic fatty liver disease in obese children.
    Sartorio A; Del Col A; Agosti F; Mazzilli G; Bellentani S; Tiribelli C; Bedogni G
    Eur J Clin Nutr; 2007 Jul; 61(7):877-83. PubMed ID: 17151586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-alcoholic fatty liver disease and its association with clinical and biochemical variables in obese children and adolescents: effect of a one-year intervention on lifestyle].
    Santomauro M; Paoli-Valeri M; Fernández M; Camacho N; Molina Z; Cicchetti R; Valeri L; Dávila de Campagnaro E; Arata-Bellabarba G
    Endocrinol Nutr; 2012; 59(6):346-53. PubMed ID: 22717644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
    Tilg H; Moschen A
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease decrease in obese adolescents after multidisciplinary therapy.
    Tock L; Prado WL; Caranti DA; Cristofalo DM; Lederman H; Fisberg M; Siqueira KO; Stella SG; Antunes HK; Cintra IP; Tufik S; de Mello MT; Dâmaso AR
    Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1241-5. PubMed ID: 17099371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative correlation between neuropeptide Y/agouti-related protein concentration and adiponectinemia in nonalcoholic fatty liver disease obese adolescents submitted to a long-term interdisciplinary therapy.
    de Piano A; Tock L; Carnier J; Oyama LM; Oller do Nascimento CM; Martinz AC; Foschini D; Sanches PL; Ernandes RM; de Mello MT; Tufik S; Dâmaso AR
    Metabolism; 2010 May; 59(5):613-9. PubMed ID: 19942238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal liver function in children with metabolic syndrome from a UK-based obesity clinic.
    Wei C; Ford A; Hunt L; Crowne EC; Shield JP
    Arch Dis Child; 2011 Nov; 96(11):1003-7. PubMed ID: 21097793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease.
    de Piano A; Prado WL; Caranti DA; Siqueira KO; Stella SG; Lofrano M; Tock L; Cristofalo DM; Lederman H; Tufik S; de Mello MT; Dâmaso AR
    J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):446-52. PubMed ID: 17414142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients.
    Forlano R; Ippolito AM; Iacobellis A; Merla A; Valvano MR; Niro G; Annese V; Andriulli A
    Gastrointest Endosc; 2010 May; 71(6):927-33. PubMed ID: 19863955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study.
    Reinehr T; Schmidt C; Toschke AM; Andler W
    Arch Dis Child; 2009 Jun; 94(6):437-42. PubMed ID: 19224892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.